Your browser is no longer supported. Please, upgrade your browser.
PLXP PLx Pharma Inc. daily Stock Chart
PLx Pharma Inc.
Index- P/E- EPS (ttm)-1.18 Insider Own5.20% Shs Outstand9.16M Perf Week3.82%
Market Cap53.82M Forward P/E- EPS next Y-1.12 Insider Trans146.80% Shs Float8.67M Perf Month98.67%
Income-10.80M PEG- EPS next Q-0.29 Inst Own29.60% Short Float1.62% Perf Quarter66.77%
Sales0.05M P/S990.74 EPS this Y68.00% Inst Trans1.56% Short Ratio5.99 Perf Half Y53.33%
Book/sh-2.15 P/B- EPS next Y8.90% ROA-68.00% Target Price9.00 Perf Year27.23%
Cash/sh1.01 P/C5.91 EPS next 5Y40.00% ROE73.20% 52W Range1.80 - 6.42 Perf YTD36.84%
Dividend- P/FCF- EPS past 5Y22.60% ROI182.10% 52W High-6.85% Beta4.97
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low232.22% ATR0.38
Employees10 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)82.33 Volatility6.11% 8.71%
OptionableNo Debt/Eq- EPS Q/Q-354.10% Profit Margin- Rel Volume1.69 Prev Close5.99
ShortableYes LT Debt/Eq- EarningsNov 16 AMC Payout- Avg Volume23.37K Price5.98
Recom2.50 SMA2037.45% SMA5063.47% SMA20073.30% Volume39,534 Change-0.17%
May-18-20Resumed JMP Securities Mkt Outperform $15 → $10
Apr-12-19Resumed Janney Buy
Jan-14-19Downgrade Raymond James Outperform → Mkt Perform
Nov-27-20 01:23PM  
Nov-16-20 04:05PM  
Nov-12-20 05:30PM  
Nov-03-20 06:50AM  
Sep-14-20 04:30PM  
Sep-03-20 11:34AM  
Aug-24-20 11:33AM  
Aug-14-20 08:26AM  
Aug-05-20 04:30PM  
Jun-04-20 09:33PM  
Jun-02-20 11:26AM  
May-18-20 04:30PM  
May-15-20 06:50AM  
May-04-20 06:50AM  
Mar-13-20 08:50AM  
Mar-03-20 06:50AM  
Feb-21-20 06:50AM  
Jan-30-20 07:30AM  
Jan-23-20 10:21AM  
Jan-07-20 06:50AM  
Jan-06-20 06:50AM  
Nov-30-19 11:39AM  
Nov-26-19 03:33AM  
Nov-19-19 10:33AM  
Nov-08-19 06:50AM  
Oct-28-19 06:50AM  
Sep-13-19 09:44PM  
Sep-10-19 12:03PM  
Sep-03-19 06:50AM  
Aug-28-19 04:30PM  
Aug-09-19 06:50AM  
Aug-02-19 10:30AM  
Jul-30-19 04:30PM  
Jul-10-19 07:16AM  
Jun-19-19 07:00AM  
Jun-11-19 12:50PM  
Jun-10-19 04:30PM  
May-21-19 11:34AM  
May-10-19 06:50AM  
May-03-19 10:30AM  
May-02-19 06:50AM  
Mar-26-19 06:30PM  
Mar-08-19 06:50AM  
Feb-25-19 04:30PM  
Feb-20-19 04:55PM  
Feb-14-19 11:30AM  
Jan-17-19 09:55AM  
Dec-20-18 07:32PM  
Dec-18-18 04:30PM  
Nov-19-18 09:31AM  
Nov-09-18 06:50AM  
Nov-01-18 07:00AM  
Oct-01-18 08:57AM  
Sep-10-18 04:30PM  
Aug-10-18 07:00AM  
Jun-11-18 04:30PM  
May-11-18 06:50AM  
Apr-24-18 07:50AM  
Mar-23-18 06:50AM  
Mar-15-18 04:30PM  
Nov-21-17 07:29PM  
Nov-10-17 06:00AM  
Nov-09-17 06:56PM  
PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing the PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce novel gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention and treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg, a GI-safer ibuprofen product for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HADDEN JOHNDirectorNov 25Buy5.485002,7382,690Nov 25 04:08 PM
Valentino Michael JExecutive ChairmanNov 18Buy3.79264,9001,003,176461,690Nov 20 07:46 PM
O'Connor Rita MChief Financial OfficerSep 02Buy3.832,1208,12712,970Sep 03 08:49 AM
O'Connor Rita MChief Financial OfficerSep 01Buy3.744,50016,83710,850Sep 03 08:49 AM
O'Connor Rita MChief Financial OfficerAug 21Buy3.974,05016,0916,350Aug 24 09:12 AM
O'Connor Rita MChief Financial OfficerAug 20Buy3.772,3008,6662,300Aug 24 09:12 AM